Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.
FAQs
Experian plc (EXPN) Share Forecast, Price Targets and Analysts Predictions - TipRanks.com? ›
EXPN Stock 12 Month Forecast
What is the forecast for Experian shares? ›The 13 analysts offering 12 month price targets for Experian plc have a median target of 3,622.87, with a high estimate of 4,277.42 and a low estimate of 2,516.17. The median estimate represents a 9.42% increase from the last price of 3,311.00.
Are Experian shares worth buying? ›Forecasts. In the H1 report, Experian said that it now expects organic revenue growth in the range of 4% to 6% and modest margin accretion for the FY2024 — the current financial year. Analysts are now expecting the world's largest credit data company to deliver earnings per share of £1.02.
Why is Experian share price falling? ›Shares in Experian fell sharply on Wednesday after the data services firm reported lower full-year profits and adopted a more cautious approach to the current year.
What is the target price for Dei tipranks? ›The average price target is $14.33 with a high forecast of $15.00 and a low forecast of $14.00. The average price target represents a 8.07% change from the last price of $13.26.
Who is the most accurate stock predictor? ›Zacks Ultimate has proven itself as one of the most accurate stock predictors for more than three decades. Incepted in 1988, this established service has produced phenomenal returns for its members. In fact, since 1998, Zacks Ultimate has generated average annualized returns of 24.3%.
What is the top stock forecast website? ›1. Best overall: Stock Analysis. Stock Analysis is the best website for free stock information for regular investors. You can think of it like Yahoo Finance, but better — it's faster, has more comprehenseive and accurate data, with a more user-friendly interface.
Can Experian be trusted? ›Credit scores from the three main bureaus (Experian, Equifax, and TransUnion) are considered accurate. The accuracy of the scores depends on the accuracy of the information provided to them by lenders and creditors.
What are the disadvantages of Experian? ›The main disadvantage of Experian is that, unlike FICO, it is rarely used as a stand-alone tool to make credit decisions. Even lenders that review credit reports in detail rather than go off a borrower's numerical score often look at results from all three bureaus, not just Experian.
Why is it risky to buy stocks on credit? ›Borrowing money you cannot repay
And if you lose money with your investment, you may face more money owed in credit card fees on the balance, due to late or missed payments, and take a credit score hit.
Why is it bad if share prices fall? ›
Key Takeaways. When a stock tumbles and an investor loses money, the money doesn't get redistributed to someone else. Drops in account value reflect dwindling investor interest and a change in investor perception of the stock.
Why is my Experian so much higher? ›Because your credit reports can differ, your scores are unlikely to be the same. Your credit scores are determined solely by the information in your credit reports and if that information is different across your reports, your credit scores will also be different.
Is Experian a big company? ›Company Profile
We support clients in more than 100 countries and employ approximately 21,700 people in 30 countries.
Based on analysts offering 12 month price targets for SO in the last 3 months. The average price target is $74.91 with a high estimate of $82 and a low estimate of $66.
What is the stock price forecast for Equifax? ›What are analysts forecasts for Equifax stock? The 75 analysts offering price forecasts for Equifax have a median target of 229.60, with a high estimate of 315.00 and a low estimate of 150.00. The median estimate represents a 98.54 difference from the last price of 226.24.
Is Equifax a good investment? ›Good news, investors! Equifax is still a bargain right now. Our valuation model shows that the intrinsic value for the stock is $343.29, but it is currently trading at US$244 on the share market, meaning that there is still an opportunity to buy now.
